Safe and effective 6-thioguanine treatment of a thiopurine S-methyltransferase deficient Crohn's disease patient using therapeutic drug monitoring

被引:0
|
作者
Wong, D. R. [2 ]
Mares, W. G. N. [1 ]
Gilissen, L. P. L. [3 ]
Masclee, A. A. M. [1 ]
Engels, L. G. J. B. [2 ]
Neef, C. [1 ]
Hooymans, P. M. [2 ]
机构
[1] Univ Hosp Maastricht, Maastricht, Netherlands
[2] Orbis Med Ctr, Sittard, Netherlands
[3] Catharina Hosp, Eindhoven, Netherlands
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:138 / 138
页数:1
相关论文
共 50 条
  • [1] Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoring
    Mares, W. G. N.
    Wong, D. R.
    Gilissen, L. P. L.
    Masclee, A. A. M.
    Hooymans, P. M.
    Engels, L. G. J. B.
    [J]. JOURNAL OF CROHNS & COLITIS, 2009, 3 (02): : 128 - 130
  • [2] Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine
    Kaskas, BA
    Louis, E
    Hindorf, U
    Schaeffeler, E
    Deflandre, J
    Graepler, F
    Schmiegelow, K
    Gregor, M
    Zanger, UM
    Eichelbaum, M
    Schwab, M
    [J]. GUT, 2003, 52 (01) : 140 - 142
  • [3] Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine
    Bayoumy, Ahmed B.
    Mulder, Chris J. J.
    Loganayagam, Aathavan
    Sanderson, Jeremy D.
    Anderson, Simon
    Boekema, Paul J.
    Derijks, Luc J. J.
    Ansari, Azhar R.
    [J]. THERAPEUTIC DRUG MONITORING, 2021, 43 (05) : 617 - 623
  • [4] Thiopurine S-methyltransferase activity in human erythrocytes:: a new HPLC method using 6-thioguanine as substrate
    Kröplin, T
    Weyer, N
    Gutsche, S
    Iven, H
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) : 265 - 271
  • [5] Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate
    T. Kröplin
    N. Weyer
    S. Gutsche
    H. Iven
    [J]. European Journal of Clinical Pharmacology, 1998, 54 : 265 - 271
  • [6] Azathioprine-induced severe aplastic anaemia in thiopurine S-methyltransferase deficient patient with Crohn's disease
    Zdziarska, Barbara
    Kurzawski, Mateusz
    Wierzbicka-Paczos, Ewa
    Kozlowska, Anna
    Chosia, Maria
    Pawlik, Andrzej
    Drozdzik, Marek
    [J]. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 30 (1-2) : 1 - 3
  • [7] Severe pancytopenia and aspergillosis caused by thioguanine in a thiopurine S-methyltransferase deficient patient: a case report
    de Hoogd, Sjoerd
    Wong, Dennis R.
    de Vries, Durk R.
    Harmsze, Ankie M.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (12) : 1592 - 1596
  • [8] Determination of thiopurine S-methyltransferase activity in erythrocytes using 6-thioguanine as substrate and a non-extraction liquid chromatographic technique
    Ford, LT
    Berg, JD
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 798 (01): : 111 - 115
  • [9] The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease
    Ha, Changhee
    Kim, Eun Sil
    Kwon, Yiyoung
    Choe, Yon Ho
    Kim, Mi Jin
    Lee, Soo-Youn
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2020, 13 : 665 - 671
  • [10] Extended thiopurine metabolite assessment during 6-thioguanine therapy for immunomodulation in Crohn's disease
    de Boer, N. K. H.
    Derijks, L. J. J.
    Keizer-Garritsen, J. J.
    Lambooy, L. H. J.
    Ruitenbeek, W.
    Hooymans, P. M.
    van Bodegraven, A. A.
    de Jong, D. J.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (02): : 187 - 191